Publication | Open Access
The effect of Benzothiazolone‐2 on the expression of Metallothionein‐3 in modulating Alzheimer's disease
14
Citations
18
References
2017
Year
Benzothiazolone-2 compounds significantly enhanced MT-3 protein and mRNA levels. The compounds can be looked upon as one of the probable lead compounds for future drug designing experiments in the treatment of Alzheimer's disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1